ScholarWorks@Hanyang University: Browsing ScholarWorks

Cho, Soo-Kyung; Sakai, Ryoko; Nanki, Toshihiro; Koike, Ryuji; Watanabe, Kaori; Yamazaki, Hayato; Nagasawa, Hayato; Tanaka, Yoshiya; Nakajima, Atsuo; Yasuda, Shinsuke, et al.

ArticleIssue Date2014CitationModern Rheumatology, v.24, no.4, pp 572 - 579PublisherSpringer Verlag

A Comparison Of The Clinical Effectiveness Of Treatment Strategies For Active RA Patients: Using a Prospective Biologic Registry (BIOPSY) and an RA Specific Cohort (KORONA)Go to Link

Sung, Yoon-Kyoung; Cho, Soo-Kyung; Choi, Chan-Bum; Won, Soyoung; Bang, So-Young; Cha, Hoon-Suk; Choe, Jung-Yoon; Chung, Won Tae; Hong, Seung-Jae; Jun, Jae-Bum, et al.

ConferenceIssue Date2013Citation77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, pp.S571PublisherWILEY-BLACKWELLPlaceUS; San Diego, CA

A Genome- Wide Association Study of Copy Number Variations Identifies the Deletion Associated with Efficacy of TNF-Alpha Blocker Therapy in Korean Patients with Rheumatoid Arthritis

유대현

ConferenceIssue Date2019PlaceAtlanta, USA

A Genome-Wide Association Study of Copy Number Variations Identifies the Deletion Associated with Efficacy of TNF-Alpha Blocker Therapy in Korean Patients with Rheumatoid Arthritis Go to Link

Gu, Ki-Nam; Bang, So-Young; Lee, Hye-Soon; Park, Youngho; Kang, Juyeon; Kim, Ji-Soong; Nam, Bora; Yoo, Hyun-Seung; Shin, Jung-Min; Lee, Yeon-Kyung, et al.

ConferenceIssue Date2019Citation2019 ACR/ARP Annual MeetingPublisherWILEYPlaceUS

A Korean Multicenter Observational Study of Disease Activity Changes in BIologic versus Non-biologic Users with Seropositive Rheumatoid Arthritis

유대현

ConferenceIssue Date2016Place나인트리 컨벤션, 서울

SCISCIESCOPUS

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis Go to Link

Yoo, Dae Hyun; Suh, Chang-Hee; Shim, Seung Cheol; Jeka, Slawomir; Cons-Molina, Francisco Fidencio; Hrycaj, Pawel; Wiland, Piotr; Lee, Eun Young; Medina-Rodriguez, Francisco G.; Shesternya, Pavel, et al.

ArticleIssue Date2017CitationAnnals of the Rheumatic Diseases, v.76, no.3, pp 566 - 570PublisherBMJ Publishing Group

SCISCIESCOPUS

A NOVEL FORMULATION OF CT-P13 FOR SUBCUTANEOUS ADMINISTRATION: 30 WEEK RESULTS FROM A PART 2 OF PHASE I/III RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH RHEUMATOID ARTHRITIS Go to Link

Westhovens, Rene; Wiland, Piotr; Zawadzki, Marek; Ivanova, Delina; Berrocal, Alfredo; Chalouhi, Elias; Balazs, Eva; Shevchuk, Sergii; Eliseeva, Larisa; Stanislavchuk, Mykola, et al.

ArticleIssue Date2019CitationAnnals of the Rheumatic Diseases, v.78, pp 1158 - 1159PublisherBMJ Publishing Group

SCISCIESCOPUS

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study Go to Link

Yoo, Dae Hyun; Racewicz, Artur; Brzezicki, Jan; Yatsyshyn, Roman; Arteaga, Edgardo Tobias; Baranauskaite, Asta; Abud-Mendoza, Carlos; Navarra, Sandra; Kadinov, Vladimir; Sariego, Irmgadt Goecke, et al.

ArticleIssue Date2016CitationArthritis Research & Therapy, v.18PublisherBioMed Central

A pilot trial of tocilizumab for refractory poatients with adult onset Still's disease

유대현

ConferenceIssue Date2013PlaceIFEMA, Madrid, Spain

SCISCIESCOPUS

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study Go to Link

Park, Won; Hrycaj, Pawel; Jeka, Slawomir; Kovalenko, Volodymyr; Lysenko, Grygorii; Miranda, Pedro; Mikazane, Helena; Gutierrez-Urena, Sergio; Lim, MieJin; Lee, Yeon-Ah, et al.

ArticleIssue Date2013CitationAnnals of the Rheumatic Diseases, v.72, no.10, pp 1605 - 1612PublisherBMJ Publishing Group

SCISCIESCOPUS

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study Go to Link

Yoo, Dae Hyun; Hrycaj, Pawel; Miranda, Pedro; Ramiterre, Edgar; Piotrowski, Mariusz; Shevchuk, Sergii; Kovalenko, Volodymyr; Prodanovic, Nenad; Abello-Banfi, Mauricio; Gutierrez-Urena, Sergio, et al.

ArticleIssue Date2013CitationAnnals of the Rheumatic Diseases, v.72, no.10, pp 1613 - 1620PublisherBMJ Publishing Group

A randomized double blinded phase 1 study demonstrates equivalence in pharmacokinetics, safety, and efficacy of CT-P-13 and infliximab in patients with ankylosing spondylitis

유대현

ConferenceIssue Date2012PlaceBerlin

A randomized double blinded phase 3 study demonstrates clinical equivalence of CT-P-13 to infliximab when co-administered with methotrexate in patients with active rheumatoid arthritis

유대현

ConferenceIssue Date2012PlaceBerlin

SCOPUS

A randomized, double-blind, placebo-controlled, phase III study of the human anti-tumor necrosis factor antibody adalimumab administered as subcutaneous injections in Korean rheumatoid arthritis patients treated with methotrexate Go to Link

Kim, Ho-Youn; Lee, Soo-Kon; Song, Yeong Wook; Yoo, Dae Hyun; Koh, Eun-Mi; Yoo, Bin; Luo, Allison

ArticleIssue Date2007CitationAPLAR Journal of Rheumatology, v.10, no.1, pp 9 - 16PublisherBlackwell Publishing Inc.

1 2 3 4 5 6 7 8 9 10 next last

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by 80Author

BROWSE